In vivo study on the roles of cytochrome P450 enzymes for metabolism of 3,4-methylenedioxymethamphetamine (Ecstasy) in rats

This publication has 20 references indexed in Scilit:

• Urinary excretion of the main metabolites of 3,4-methylenedioxymethamphetamine (MDMA), including the sulfate and glucuronide of 4-hydroxy-3-methoxymethamphetamine (HMMA), in humans and rats
  Xenobiotica, 2008
• Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine
  Journal of Chromatography B, 2007
• Human Pharmacology of MDMA
  Therapeutic Drug Monitoring, 2004
• The Role of Metabolism in 3,4-(±)-Methylenedioxyamphetamine and 3,4-(±)-Methylenedioxymethamphetamine (Ecstasy) toxicity
  Therapeutic Drug Monitoring, 2004
• 3,4-Methylenedioxymethamphetamine (“Ecstasy”) induces apoptosis of cultured rat liver cells
  Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
• Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs (‘Ecstasy’)
  Toxicology Letters, 2000
• Non‐linear pharmacokinetics of MDMA (‘ecstasy’) in humans
  British Journal of Clinical Pharmacology, 2000
• Cytochromes P-450 in rats: structures, functions, properties and relevant human forms
  Xenobiotica, 1992
• In vivo formation of aromatic hydroxylated metabolites of 3,4-(methylenedioxy)methamphetamine in the rat: Identification by ion trap tandem mass spectrometric (MS/MS and MS/MS/MS) techniques
  Journal of Mass Spectrometry, 1991
• In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector
  Chemical Research in Toxicology, 1988